Oncology & Cancer

An epigenetic marker can predict survival in childhood leukaemia

A molecular epigenetic marker is important for distinguishing patients with childhood leukaemia at high and low risk of relapse even at the time of diagnosis. It can be important to adapt early on as to what treatment to ...

Oncology & Cancer

Laying siege to chemoresistance

To date, tests have only been carried out on cells, but a piece of research conducted by the Department of Genetics at the UPV/EHU's Faculty of Medicine in collaboration with MD Anderson and the CNIO is opening up the door ...

Oncology & Cancer

Genetic markers hope for new brain tumor treatments

Researchers at The University of Nottingham have identified three sets of genetic markers that could potentially pave the way for new diagnostic tools for a deadly type of brain tumour that mainly targets children.

page 2 from 3